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Objectives: The negative effects of malnutrition on the prognosis of hospitalized patients are well documented;
however, less known is the awareness and knowledge of health care professionals about this complication. The
aim of this study was to evaluate the trend of the requests for nutritional consultation in years and the prescrip-
tion of artiﬁcial nutrition (AN), for adult patients at a university hospital in southern Italy in the years 2004, 2008,
2012, and 2016 to assess the progress of medical teams concerning awareness of hospital malnutrition.
Methods: This was a retrospective study that evaluated the time trend of nutritional consultation requests and
related prescription of AN, for adult patients at a university hospital in southern Italy in the years 2004, 2008,
2012, and 2016. Of 112 233 inpatients, 2505 received a nutritional consultation with the prescription of AN.
Results: The number of patients on AN increased from 507 of 33 240 (1.52%) in 2004 to 730 of 29 195 (2.5%) in
2008 (P < 0.001), remaining almost stable in 2012 and 2016.
The request for AN was quite equally distributed between surgical (51.5%) and medical wards (48.5%), with a
prevalence among patients with oncologic diseases (806 patients [65.6%]). As for nononcologic diseases,
20.4% involved the gastrointestinal tract and 6.3% the nervous system.
Throughout the 12 y of observation, parenteral nutrition was the main prescribed support (59.8%) followed
by oral nutritional supplements (26.1%) and enteral nutrition (9.3%). Mean nutritional intervention duration
was 11 d (§10.8 d).
Conclusions: The request of AN for hospitalized patients increased over time, probably owing to improved
medical consciousness of the potential risks for malnutrition and the availability of a specialized clinical
nutrition team.
© 2018 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license.
(http://creativecommons.org/licenses/by-nc-nd/4.0/)Keywords:
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Protein energy malnutrition (PEM) in hospitalized patients is
clearly associated with increased morbidity and mortality, pro-
longed hospitalization, more frequent readmissions, and increased
health care costs [14]. Malnutrition in the hospital setting can
develop as a consequence of insufﬁcient nutrient intake, impaired
absorption, increased metabolic demands during illness, increased
catabolism, or a combination of some or all of these factors [5,6].For these reasons, the awareness and knowledge of health care pro-
fessionals about malnutrition and its related side effects should be con-
stantly monitored and improved in hospital and after discharge [7,8].
This retrospective study evaluated the trend of the requests for
nutritional consultation in years and the prescription of artiﬁcial
nutrition (AN), for patients hospitalized at Federico II University
Hospital in Naples, Italy (and Europe) in the years 2004, 2008,
2012, and 2016 to assess the progress of medical teams concerning
awareness of hospital malnutrition.Materials and methods
All patients hospitalized in the years 2004, 2008, 2012, and 2016 at the Feder-
ico II University Hospital in Naples, Italy, requiring a nutritional consultation were
evaluated. Inpatients on the pediatric wards and of the intensive care unit (ICU)
Table 1
Prevalence of hospitalized patients on artiﬁcial nutrition at Federico II University Hospital
Data 2004 2008 2012 2016 Total
Total inpatient admissions* 33 240 29 195 25 988 23 810 112 233
Number of patients on AN (%) 507y (1.52) 730y (2.5) 691 (2.65) 577 (2.42) 2505 (2.23)
Sex
Men (%) 282 (55.5) 442 (60.6) 340 (49.2) 327 (56.5) 1391 (55.5)
Women (%) 225 (44.5) 288 (39.4) 351 (50.8) 250 (43.5) 1114 (44.5)
Age, y
Mean § SD; median
(min/max)
59.6 § 17.7; 64 (14/93) 60.8 § 16.4; 63 (16/93) 57.6 § 18.7; 63 (16/93) 60.8 § 16.9; 63 (15/101) 59.3 § 17.6; 61 (14/91)
Total
Cancer/Noncancer patients n (%) 301/206 (59/41) 465/265 (64/36) 327/364 (47/53) 295/282 (51.1/48.9) 1388/1117 (55.4/43)
Surgery wards
Patients, n (%) 293 (58) 346 (47) 353 (51) 236 (40.9) 1228 (51.5)
Cancer/Noncancer patients n (%) 212/81 (72/28) 251/95 (73/27) 214/139 (61/39) 129/107 (54.7/45.3) 806/422 (65.6/34.4)z
Medical wards
Patients, n (%) 214 (42) 384 (53) 338 (49) 341 (59.1) 1277 (48.5)
Cancer/Noncancer patients n (%) 89/125 (41.8/58.2) 214/170 (56/44) 114/224 (33.1/66.9) 166/175 (48.7/51.3) 583/694 (45.7/54.3)
SD, standard deviation.
*Excluded intensive care and pediatric patients.
y2008 vs 2004; P < 0.0001.
zCancer/Noncancer in surgery vs Cancer/Noncancer in medicine; P< 0.0001s.
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the following data were collected:
 Demographic and clinical data: age, sex; primary disease, comorbidities, and
complications
 Anthropometry: weight and height, body mass index (BMI; kg/m2) when pos-
sible measured with a platform scale and an altimeter. In bedridden patients,
height was derived by kneeheel length (KH), and weight was derived by KH,
calf and arm circumferences, and subscapular skinfold thickness, using appro-
priate equations
 Blood parameters of nutritional interest: albumin, lymphocytes, pseudocholin-
esterase (PChE)
 Indication to withhold AN, type of AN prescribed, route of administration,
duration of treatment, reasons for withdrawing
 Underlying clinical condition: classiﬁed as oncologic or nononcologic. The ﬁrst
group included head-neck cancer, upper and lower gastrointestinal (GI) tract
cancer, peritoneal carcinomatosis, and lymphomas/leukaemia, and the second
group included acute and chronic neurologic diseases, primary and secondary
anorexia, and non-neoplastic (benign) GI diseases (short bowel syndrome),
radiation enteritis, inﬂammatory bowel diseases [IBD], etc).
The prescribed AN therapy included parenteral nutrition (PN), enteral nutri-
tion (EN), oral nutritional supplements (ONS), or mixed artiﬁcial nutrition
(MN = PN + EN or PN + ONS).
Indications were anorexia, malabsorption, dysphagia, nausea or vomiting,
occlusion or subocclusion, and postoperative status. Hospitalization in medical or
surgical wards also was considered.
Main hematobiochemical parameters considered to deﬁne a patient's nutri-
tional status were serum albumin, total lymphocyte count, and serum PChE.
According to the 2000 guidelines from the Italian Society of Articiﬁcal Nutriton
and Metabolism, serum albumin values<3 g/dL, PChE <5400 U/I, and lymphocytes
<1200/mm3 were considered to be indicators of moderate malnutrition [9].
Results were expressed as the mean § SD, frequencies, and percentages. Sta-
tistical analysis was performed with SPSS version 16 (SPSS, Chicago, IL, USA). The
comparison between years for continuous variables considered was carried out by
one-way analysis of variance. Differences among the years were reported when
statistically signiﬁcant; otherwise, data were expressed as the resulting sum of the
4 y. Statistical signiﬁcance was reached for P< 0.05.
Results
Of 112,233 inpatients in 2004, 2008, 2012, and 2016, a total of
2505 inpatients received a nutritional consultation, always fol-
lowed by the prescription of AN. The number of patients on AN
increased from 2004 to 2008 (P < 0.001) and remained almost sta-
ble in the following years. The request for ANwas quite equally dis-
tributed in surgical and medical wards (51.5% versus 48.5%), with a
slight prevalence of oncologic diseases (65.6% oncologic versus34.4% nononcologic patients) in surgery wards than in medicine
wards (45.7% oncologic versus 54.3% nononcologic patients;
P < 0.001). In addition, the distribution according to sex (55.5%
men versus 44.5% women) and age (mean age 59.3 § 17.6 y) was
almost homogeneous in the years studied (Table 1).
Patients with oncologic and hematologic diseases required AN
more frequently than other patients (1497 patients [59%]). Among
nononcologic diseases, 20.4% (511) involved the GI tract, and 6.3%
(159) the nervous system. Main indications for AN were anorexia
(32.6%) and postsurgery nutrition (29.6%), followed by nausea/
vomiting (14.9%), malabsorption/diarrhea (10.1%), dysphagia
(6.7%), and occlusion/subocclusion (6.2%).
PN was the main prescribed support in all the 4 y studied
(59.8%), followed by ONS (26.1%) and EN (9.3%). MN (PN + EN or
PN +ONS) was prescribed in 4.8% of cases. By comparing the preva-
lence over time for each year of observation, a slight, but not signif-
icant, decrease in PN and an increase in EN was found, as
recommended by national and international guidelines on AN
(Table 2).
As far as BMI distribution, underweight, overweight, and
even obese patients were well represented with a slight,
although not signiﬁcant, increase over the years (19.5% over-
weight and 4.9% obese in 2004 versus 23.9% overweight and
10.1% obese in 2016).
Regarding the main hematobiochemical nutritional indicators,
34% (848 of 2335) of the patients had serum albumin values
<3 g/dL, 45% (793 of 1308) of the patients had PChE values 5400,
and 24.4% (610 of 1157) had lymphocyte counts 1200/mm3. Type
2 diabetes prevalence was 21.7% (544 of 2505 patients; Table 3).
Analyzing patients on PN, 57.8% (865 of 1497) were affected by
onco-hematologic diseases and 24.9% (373 of 1497) by GI diseases.
The main indication for PN in oncologic patients was postoperative
nutrition (53.5% [143 of 865]), whereas in nononcologic patients,
postoperative nutrition (25.2% [159 of 632]), anorexia (24.8% [157
of 632]), and malabsorption (24.1% [152 of 632]) had almost the
same prevalence (Table 4).
Of patients on EN, 65% (151 of 232) had cancer and 35% had
other diseases, with the prevalence being neurologic conditions
(58% [47 of 81]). Main indications for EN were postoperative nutri-
tion (60.3% [91 of 151]) and dysphagia (24.5% [371 of 151]) in
patients with cancer and dysphagia (56.8% [46 of 81]) in those
without (Table 4).
Table 3
BMI distribution and baseline biochemical parameters of inpatients on AN
Data 2004 2008 2012 2016 Total
BMI (kg/m2)
<18.5 (%) 74 (14.6) 85 (11.6) 106 (15.3) 81 (14) 346 (13.8)
18.524.9 (%) 214 (42.2) 358 (49) 241 (34.9) 282 (48.9) 1095 (43.7)
2529.9 (%) 99 (19.5) 135 (18.5) 112 (16.2) 138 (23.9) 484 (19.3)
30 (%) 25 (4.9) 48 (6.6) 49 (7.1) 58 (10.1) 180 (7.2)
Available information, n/N (%) 412/507 (81.3) 626/730 (85.8) 508/691 (73.5) 559/577 (96.9) 2105/2505 (84)
Albumin 3 g/dL, n (%) 201 (39.6) 244 (33.4) 189 (27.4) 214 (37.1) 848 (33.9)
Available information, n/N (%) 430/507 (84.8) 695/730 (95.2) 646/691 (93.5) 564/577 (97.7) 2335/2505 (93.2)
Lymphocytes 1200 n/mm3, n (%) 49 (50) 102 (51.5) 191 (51.5) 268 (46.4) 610 (24.4)
Available information, n/N (%) 98/507 (19.3) 198/730 (27.1) 371/691 (53.7) 559/577 (96.9) 1157/2505 (46.2)
PChE 5400 U/L, n (%) 136 (60.2) 264 (68.4) 196 (58) 197 (55) 793 (45)
Available information, n/N (%) 226/507 (44.6) 386/730 (85.8) 338/691 (73.5) 358/577 (96.9) 1308/2505 (60.6)
Diabetes prevalence, n/N (%) 68/507 (13.4) 202/730 (27.7) 152/961 (22) 122/577 (21.1) 544/2505 (21.7)
AN, artiﬁcial nutrition; BMI, body mass index; PChE, pseudocholinesterase.
Table 2
Baseline diseases, indications to and type of prescribed artiﬁcial nutrition
Disease state 2004Patientsn (%) 2008Patientsn (%) 2012Patientsn (%) 2016Patientsn (%) TotalPatientsN (%)
Onco-hematologic 302 (59.6) 459 (62.9) 327 (47.3) 391 (67.8) 1479 (59)
Gastroenterologic 60 (11.8) 117 (16) 196 (28.4) 138 (23.9) 511 (20.4)
Neurologic 30 (5.9) 52 (7.1) 39 (5.6) 38 (6.6) 159 (6.3)
Others 115 (22.7) 102 (14) 129 (18.7) 10 (18.4) 356 (14.2)
Total patients 507 730 691 577 2505
Indications 2004 2008 2012 2016 Total
Anorexia 143 (28.2) 212 (29) 283 (41) 178 (30.8) 816 (32.6)
Dysphagia 20 (3.9) 30 (4.1) 22 (3.2) 95 (16.5) 167 (6.7)
Malabsorption/Diarrhea 43 (8.5) 75 (10.3) 72 (10.4) 63 (10.9) 253 (10.1)
Nausea/vomiting 85 (16.8) 142 (19.5) 84 (12.2) 61 (10.8) 372 (14.9)
Occlusion/subocclusion 45 (8.9) 53 (7.3) 28 (4.1) 29 (5) 155 (6.2)
Postsurgery 171 (33.7) 218 (30) 202 (29.2) 151 (26.2) 742 (29.6)
Total patients 507 730 691 577 2505
Type of AN 2004 2008 2012 2016 Total
Parenteral nutrition 319 (62.9) 453 (62.1) 400 (57.9) 325 (56.3) 1497 (59.8)
Enteral nutrition 35 (6.9) 52 (7.1) 66 (9.6) 79* (13.7) 232 (9.3)
Oral nutrional supplements 151 (29.8) 169 (23.1) 182 (26.3) 153 (26.5) 655 (26.1)
Mixed nutrition 2 (0.4) 56 (7.7) 43 (6.2) 20 (3.5) 121 (4.8)
Total patients 507 730 691 577 2505
AN, artiﬁcial nutrition.
*Enteral nutrition 2016 vs 2004; P = 0.0003.
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patients on EN received lactose and gluten-free, ﬁber-enriched
industrial mixtures. PN patients received galenic personalized mix-
tures in 57.2% of cases and standardized industrial mixtures in
40.6%; moreover, during hospitalization, 2.2% of patients needed to
pass from an industrial to a galenic mixture or vice-versa. Over all
the years, there was a shift from galenic to industrial mixtures:
From 79% of galenic prescriptions in 2004 to 37.5% in 2012, and
from 21% of standard industrialized mixture prescriptions in 2004
to 56% in 2012 (P < 0.0001; Table 5).
Average nutritional intervention duration was 11 § 10.8 d
(median 7 d, range 1133 d), without signiﬁcant changes over all
the years (data not shown).
In 2008, 2012, and 2016, nearly 55% of patients were with-
drawn from AN because they returned to the natural oral route
and almost 32% required home artiﬁcial nutrition (HAN; Table 6).
Discussion
The present study evaluated the demand, in a time length of
12 y, of AN intervention in a university hospital in southern
Europe (Federico II University Hospital) to examine the trend
regarding the awareness of this concern by medical and surgicalteams. The choice to evaluate four sample years (2004, 2008,
2012, and 2016) allowed for the analysis of a long time span cor-
responding to the regular counseling of a clinical nutrition team
for hospitalized patients. The study shows that the request for AN
in hospitalized patients increased over time, particularly from
2004 to 2008, and then reached a plateau. This ﬁnding is probably
due to improved knowledge of the potential risks for malnutrition
as well as to the presence in the hospital of a dedicated clinical
nutrition team.
Indeed, the study also suggested that in addition to providing a
regular service, a dedicated AN team in general hospitals allows for
more careful consideration and evaluation of patients’ nutritional
status. We have not measured this speciﬁc topic, but we have
observed that both physicians and nurses are now paying more
attention to secondary anorexia and nutritional/catabolic status of
their patients, thus demonstrating that improved attention has
been reached since the beginning of our intervention. These results
were obtained in a relatively short period of time—in particular
from 2004 and 2008. During this 4-year period, the following
actions were taken by our team:
1. Training and updating courses on nutrition screening and nutri-
tional support indication in several clinical conditions were
Table 4
Type of disease and main indications for PN and EN in a subgroup of oncologic and nononcologic patients for years 2004, 2008, 2012 and 2016
Parenteral nutrition
Oncologic patients, n Nononcologic patients, n
Disease state 2004 2008 2012 2016 Total Disease state 2004 2008 2012 2016 Total (%)
Onco-hematologic 209 299 196 161 865 GI 41 89 145 98 373 (59)
Neurologic 6 18 11 10 45 (7.2)
Others 63 47 48 56 214 (33.8)
Total (%) 209 (24) 299 (34.6) 196 (22.8) 161 (18.6) 865 (100) Total 110 (17.4) 154 (24.4) 204 (32.3) 164 (25.9) 632 (100)
Indications 2004 2008 2012 2016 Total (%) Indications 2004 2008 2012 2016 Total (%)
Anorexia 22 39 49 25 135 (15.6) Anorexia 31 42 73 11 157 (24.8)
Dysphagia 2 2 1 19 24 (.,7) Dysphagia 0 1 1 13 15 (2.4)
Malabsorption 11 22 11 14 58 (6.7) Malabsorption 29 43 46 34 152 (24.1)
Nausea 33 59 9 8 109 (12.6) Nausea 20 28 29 29 106 (16.8)
Occlusion/subocclusion 26 33 9 8 76 (8.7) Occlusion/subocclusion 6 6 14 17 43 (6.8%)
Postop (%) 115 (55) 144 (48.2) 117 (59.7) 87 (54) 463 (53.7) Postop 24 34 41 60 159 (25.2)
Total (%) 209 (24.2) 299 (34.6) 196 (55) 161 (55) 865 (100) Total 110 (17.4) 154 (24.4) 204 (32.3) 164 (25.9) 632 (100)
Enteral nutrition
Oncological patients, n Nononcological patients, n
Disease state 2004 2008 2012 2016 Total Disease state 2004 2008 2012 2016 Total
Onco-hematology 22 30 44 55 151 GI 0 0 1 0 1
Neurologic 9 13 9 16 47
Other 4 9 12 8 33
Total (%) 22 (14.6) 30 (19.9) 44 (29.1) 55 (36.4) 151 (100) Total (%) 13 (16) 22 (27.2) 22 (27.2) 24 (29.6) 81 (100)
Indications 2004 2008 2012 2016 Total (%) Indications 2004 2008 2012 2016 Total (%)
Anorexia 0 3 0 1 4 (2.6) Anorexia 3 2 5 3 13 (16)
Dysphagia 2 5 6 24 37 (24.5) Dysphagia 5 13 8 18 44 (54.4)
Nausea 9 5 2 0 16 (10.6) Nausea 4 5 4 0 13 (16)
Occlusion/subocclusion 2 1 0 0 3 (2) Occlusion/ subocclusion 0 0 0 0 0
Postop 9 16 36 30 91 (60.3) Postop 1 2 5 3 11 (13.6)
Total (%) 22 (14.6) 30 (19.9) 44 (29.1) 55 (36.4) 151 (100) Total (%) 13 (16) 22 (27.2) 22 (27.2) 24 (29.6) 81 (100)
EN, enteral nutrition; GI, gastrointestinal; PN, parenteral nutrition; postop, postoperative.
Table 5
Parenteral nutrition: Type of prescribed mixtures
Type of mixtures 2004 2008 2012 2016 Total
Galenic* (%) 252 (79) 317 (70) 166 (41.5) 122 (37.5) 857 (57.2)
Industrialy (%) 67 (21) 113 (24.9) 222 (55.5) 182 (56) 608 (40.6)
Galenic$ Industrial (%) 0 23 (5.1) 12 (3) 40 (6.5) 32 (2.2)
Total 319 453 400 325 1497
*Galenic 2004 vs 2008, P = 0.005; 2012 vs 2008, P < 0.0001; 2012 vs 2004, P< 0.0001.
yIndustrial 2004 vs 2012, P < 0.0001; 2008 vs 2012, P < 0.0001.
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drafted and distributed to all hospital wards.
2. A dietitian started to cooperate with the physician during the
daily counseling in the wards.
3. The clinical nutrition service for inpatients, in particular prepa-
ration and distribution of the prescribed nutritional therapy,
was better supported by the pharmacy department.
4. The apparent decrease of AN prescription between 2012 and
2016 is due to the decrease in the overall admission of inpa-
tients. Ultimately, in fact, the percentages of patients treated
with AN did not decrease, but remained substantially
unchanged in the time.Table 6
Reasons for AN interruption
2004 2008
Discharge/Oral nutrition, n (%) nd 388 (53.2)
Home parenteral nutrition, n (%) nd 227 (31.1)
Ward change, n (%) nd 39 (5.3)
Deaths, n (%) nd 32 (4.4)
NA Complications, n (%) nd 6 (0.8)
Therapy change, n (%) nd 38 (5.2)
Total, n (%) nd 730 (100)
AN, artiﬁcal nutrition; NA, not applicable; nd, no data.Hospital malnutrition is a growing clinical burden that requires
a dedicated clinical nutrition medical team that can properly iden-
tify and treat the condition [10,11].
The increased prevalence of hospital malnutrition also may be
due to population aging and to increases in the incidence of cancer,
neurologic diseases, and IBDs; the obesity epidemic, and the fact
that PEM may be masked and not detected if not carefully investi-
gated (i.e., sarcopenic obesity) [1214]. Malnutrition is accompa-
nied by an increased risk for clinical complications, including
sepsis, pneumonia, pressure ulcers, and wound dehiscence, with a
consequent increase in the duration and costs of hospitalization.
Currently, it has been widely demonstrated that a strong2012 2016 Total
386 (55.9) 321 (55.6) 1095 (54.8)
222 (32.1) 189 (32.8) 638 (31.9)
15 (2.2) 12 (2.1) 66 (3.3)
10 (1.4) 13 (2.2) 55 (2.8)
1 (0.1) 3 (0.5) 10 (0.5)
57 (8.3) 39 (6.8) 134 (6.7)
691 (100) 577 (100) 1998 (100)
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the disease [35,13,15].
When indicated, AN can improve the effectiveness or reliability
of speciﬁc treatments for the underlying disease, prevent the
development of malnutrition, and promote healing in surgical
patients [16,17]. A report produced by the Committee of Ministers
of Health Council of Europe in 2002 demonstrated the need to raise
awareness of health professionals about the possibility of an effec-
tive treatment of PEM through an adequate, timely screening and
nutritional support [18].
The prevalence of malnutrition in hospitalized patients has
been extensively evaluated worldwide and results are still well
rooted and widespread. To our knowledge, only a few studies point
out directly the awareness of hospital malnutrition and the most
common mean used to study this situation is a survey of medical
or surgical staff, nurses, or even of the patients.
The result is rather univocal, proving poor awareness and an
underestimation of the issue, both when considering single special-
ties (e.g., oncology, surgeons, geriatrics) and other hospital wards.
For example, only 5.7% of Italian Association of Medical Oncologists
members participated in an Italian survey that evaluated the atti-
tude toward malnutrition among oncologists [19,20]. The low
response rate reﬂected the lack of interest in malnutrition and its
consequences on patient outcome. Unfortunately, a direct compari-
son with our study is not possible, mainly owing to the different
methods used to explore this issue.
More than half of inpatients requiring AN were underweight or
normal weight; 19.3% were overweight, and 7.2% were obese.
Although not statistically signiﬁcant, over the years, a growing
number of overweight and obese patients were observed, in agree-
ment with the increasing obesity epidemic [12,13].
Modality of AN support (PN, EN, or ONS) has been primarily in
agreement with the clinical condition at baseline and its complica-
tions (i.e., dysphagia, diarrhea, malabsorption, etc), also according
to the pre-existing (mostly PN) venous access.
The prevalent prescription of PN is related mostly to the clinical
condition of the inpatients: Nearly 30% were major abdominal surgery
patients, 16.3% had GI inﬂammatory diseases, 14.9% had GI toxicity as
a result of antineoplastic therapy, and 6.3% had intestinal occlusion.
In addition, in some cases, particularly oncologic and hemato-
logic patients, the choice between the enteral or parenteral route
of administration may depend on the primary disease site (causing
mechanical dysphagia or intestinal obstruction) and the side effects
of anticancer treatments (nausea, vomiting, diarrhea for GI toxic-
ity). Often, the presence of an already implanted central venous
catheter addressed the choice toward the PN route. [18]
Furthermore, in most postoperative inpatients with an unstable
metabolic/hydroelectrolite balance, the PN route has been indi-
cated and, when necessary, galenic mixtures have been prescribed.
The slight trend in the reduced number of PN patients in favor
of the increase of EN patients suggests an improved adherence to
the guidelines for AN, although much remains to be done [16,17].
As far as the type of nutritional mixtures (industrial versus
galenic), the decrease in the prescription of galenic mixtures was
probably due to the current larger choice, as far as macro- and
micronutrients, of the composition of commercially available
industrial mixtures.
When comparing the duration of AN intervention between the
different groups of patients, no signiﬁcant differences were shown.
The observation in this manuscript concerned the time spent as
inpatients only; however, when needed, patients continued on
HAN as needed (31.9%, as reported in Table 6).
This retrospective observational study had some limitations.
First, the nutritional status and the consequent nutritional supportin the ICU was not evaluated because of its own management.
Therefore, there is a lack information on the nutritional status of
most acute patients. We did not report an AN complications rate,
although this was not particularly relevant at our preliminary
observation. Finally, the study regarded mostly a direct evaluation
of the attention given by the inward health professional to the clin-
ical (artiﬁcial) nutrition intervention.
On the other hand, the strength of this study was mostly related
to the length of the observation (12 y).
The cost evaluation of nutritional therapy did not fall into the
aims of the present study. However, because malnourishment in
patients undeniably is associated with increased costs, longer hos-
pital stay, and more intensive treatment, the evaluation of the
cost-to-beneﬁt ratio, provided the accuracy of the indication or
prescription, should be undertaken.
As far as clinical nutrition outcome, because patients in the ICU
were excluded from the study, the natural feeding rehabilitation or
prescription of HAN have been considered.
Conclusion
The improved awareness over the years by hospital staff of the
presence of malnutrition and the efﬁcacy of AN treatment strongly
supports the integration of medical school courses with informa-
tion on nutritional screening and assessment, nutritional treat-
ments (in particular AN), and a reorganization of regular courses
and updating of meetings to constantly increase attention given to
this relevant clinical issue.
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